Expression of CD24 in adenocarcinomas of the pancreas correlates with higher tumor grades.

@article{Jacob2004ExpressionOC,
  title={Expression of CD24 in adenocarcinomas of the pancreas correlates with higher tumor grades.},
  author={Juliane Jacob and Joachim Bellach and Robert Gr{\"u}tzmann and Ingo Alldinger and Christian Pilarsky and Manfred Dietel and Glen Kristiansen},
  journal={Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]},
  year={2004},
  volume={4 5},
  pages={454-60}
}
BACKGROUND/AIMS CD24 is expressed in hematological malignancies as well as in a large variety of solid tumors and is often associated with a more aggressive course of the disease. We aimed to evaluate CD24 protein expression in pancreatic adenocarcinomas and to correlate it to clinicopathological data including patient survival. METHODS 95 primary adenocarcinomas of the pancreas were immunostained using a monoclonal CD24 antibody (Ab-2, clone 24C02). Staining was evaluated as negative versus… CONTINUE READING